Lappaol F regulates the cell cycle by activating CDKN1C/p57 in human colorectal cancer cells

References

• Borriello A, Caldarelli I, Bencivenga D, Criscuolo M, Cucciolla V, Tramontano A, Oliva A, Perrotta S, Della Ragione F. 2011. p57(Kip2) and cancer: time for a critical appraisal. Mol Cancer Res. 9(10):1269–1284.
   PubMed Web of Science ®Google Scholar
• Cheng AY, Chien YC, Lee HC, Hsieh YH, Yu YL. 2020. Water-extracted Ganoderma lucidum induces apoptosis and S-phase arrest via cyclin-CDK2 pathway in glioblastoma cells. Molecules. 25(16):3585.
   PubMedGoogle Scholar
• Ehmer U, Sage J. 2016. Control of proliferation and cancer growth by the Hippo signaling pathway. Mol Cancer Res. 14(2):127–140.
   PubMed Web of Science ®Google Scholar
• Fotedar A, Cannella D, Fitzgerald P, Rousselle T, Gupta S, Doree M, Fotedar R. 1996. Role for cyclin A-dependent kinase in DNA replication in human S phase cell extracts. J Biol Chem. 271(49):31627–31637.
   PubMed Web of Science ®Google Scholar
• Han YH, Kee JY, Kim DS, Mun JG, Jeong MY, Park SH, Choi BM, Park SJ, Kim HJ, Um JY, et al. 2016. Arctigenin inhibits lung metastasis of colorectal cancer by regulating cell viability and metastatic phenotypes. Molecules. 21(9):1135.
   PubMed Web of Science ®Google Scholar
• Hoxha S, Shepard A, Troutman S, Diao H, Doherty JR, Janiszewska M, Witwicki RM, Pipkin ME, Ja WW, Kareta MS, et al. 2020. YAP-mediated recruitment of YY1 and EZH2 represses transcription of key cell-cycle regulators. Cancer Res. 80(12):2512–2522.
   PubMed Web of Science ®Google Scholar
• Lai J, Lin X, Cao F, Mok H, Chen B, Liao N. 2021. CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients. J Cell Mol Med. 25(19):9390–9401.
   PubMed Web of Science ®Google Scholar
• Lee M, Goraya N, Kim S, Cho SH. 2018. Hippo-yap signaling in ocular development and disease. Dev Dyn. 247(6):794–806.
   PubMed Web of Science ®Google Scholar
• Lee MH, Reynisdóttir I, Massagué J. 1995. Cloning of p57kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9(6):639–649.
   PubMed Web of Science ®Google Scholar
• Li JQ, Wu F, Usuki H, Kubo A, Masaki T, Fujita J, Bandoh S, Saoo K, Takeuchi H, Kuriyama S, et al. 2003. Loss of p57KIP2 is associated with colorectal carcinogenesis. Int J Oncol. 23(6):1537–1543.
   PubMed Web of Science ®Google Scholar
• Li T, Yang J, Yang B, Zhao G, Lin H, Liu Q, Wang L, Wan Y, Jiang H. 2020. Ketamine inhibits ovarian cancer cell growth by regulating the lncRNA-PVT1/EZH2/p57 axis. Front Genet. 11(597467):597467.
   PubMedGoogle Scholar
• Li W, Bi C, Han Y, Tian T, Wang X, Bao H, Xu X, Zhang X, Liu L, Zhang W, et al. 2019. Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57(CDKN1C) and TP53INP1 in mantle cell lymphoma. Cancer Biol Med. 16(3):530–541.
   PubMed Web of Science ®Google Scholar
• Li X, Lin YY, Tan JY, Liu KL, Shen XL, Hu YJ, Yang RY. 2021. Lappaol F, an anticancer agent, inhibits YAP via transcriptional and post-translational regulation. Pharm Biol. 59(1):619–628.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Q, Wei HC, Liang YY, Niu FJ, Li KW, Zhou SJ, Zhou CZ. 2022. Fructus arctii: an overview on its traditional uses, pharmacology and phytochemistry. J Pharm Pharmacol. 74(3):321–336.
   PubMed Web of Science ®Google Scholar
• Lim S, Kaldis P. 2013. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 140(15):3079–3093.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zeng W, Wang S, Zhao X, Guo Y, Yu P, Yin X, Liu C, Huang T. 2017. A potential role for the Hippo pathway protein, YAP, in controlling proliferation, cell cycle progression, and autophagy in BCPAP and KI thyroid papillary carcinoma cells. Am J Transl Res. 9(7):3212–3223.
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ. 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9(6):650–662.
   PubMed Web of Science ®Google Scholar
• Morgan DO. 2008. SnapShot: cell-cycle regulators I. Cell. 135(4):764–764.e1.
   PubMed Web of Science ®Google Scholar
• Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M, Shimada Y, Tsuda H, Kawano T, Inazawa J. 2011. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis. 32(3):389–398.
   PubMed Web of Science ®Google Scholar
• Noura S, Yamamoto H, Sekimoto M, Takemasa I, Miyake Y, Ikenaga M, Matsuura N, Monden M. 2001. Expression of second class of KIP protein p57KIP2 in human colorectal carcinoma. Int J Oncol. 19(1):39–47.
   PubMed Web of Science ®Google Scholar
• Oakes V, Wang W, Harrington B, Lee WJ, Beamish H, Chia KM, Pinder A, Goto H, Inagaki M, Pavey S, et al. 2014. Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle. Cell Cycle. 13(20):3302–3311.
   PubMed Web of Science ®Google Scholar
• Pateras IS, Apostolopoulou K, Niforou K, Kotsinas A, Gorgoulis VG. 2009. p57KIP2: "Kip"ing the cell under control. Mol Cancer Res. 7(12):1902–1919.
   PubMed Web of Science ®Google Scholar
• Peng Y, Feng H, Wang C, Song Z, Zhang Y, Liu K, Cheng X, Zhao R. 2021. The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression. Cell Death Dis. 12(5):427.
   PubMed Web of Science ®Google Scholar
• Reynaud EG, Guillier M, Leibovitch MP, Leibovitch SA. 2000. Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity. Oncogene. 19(9):1147–1152.
   PubMed Web of Science ®Google Scholar
• Song Y, Li X, Liu Y, Hu Y, Yang R. 2019. Arctigenin improves lipid metabolism by regulating AMP-activated protein kinase and downstream signaling pathways. J Cell Biochem. 120(8):13275–13288.
   PubMed Web of Science ®Google Scholar
• Song JY, Park R, Kim JY, Hughes L, Lu L, Kim S, Johnson RL, Cho SH. 2014. Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. Dev Biol. 386(2):281–290.
   PubMed Web of Science ®Google Scholar
• Sun Q, Liu K, Shen X, Jin W, Jiang L, Sheikh MS, Hu Y, Huang Y. 2014. Lappaol F, a novel anticancer agent isolated from plant Arctium lappa L. Mol Cancer Ther. 13(1):49–59.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Dong J. 2021. The Hippo signaling pathway in cancer: a cell cycle perspective. Cancers. 13(24):6214.
   PubMed Web of Science ®Google Scholar
• Yang X, Karuturi RK, Sun F, Aau M, Yu K, Shao R, Miller LD, Tan PB, Yu Q. 2009. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. PLoS One. 4(4):e5011.
   PubMed Web of Science ®Google Scholar